Cargando…
A new DNA vaccine expressing HspX-PPE44-EsxV fusion antigens of Mycobacterium tuberculosis induced strong immune responses
OBJECTIVE(S): Infection with tuberculosis (TB) is regarded as a major health issue. Due to the emergence of antibiotic resistance during TB treatment, prevention via vaccination is one of the most effective ways of controlling the infection. DNA vaccines are developed at a greater pace due to their...
Autores principales: | Moradi, Bagher, Sankian, Mojtaba, Amini, Yousef, Gholoobi, Aida, Meshkat, Zahra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mashhad University of Medical Sciences
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395183/ https://www.ncbi.nlm.nih.gov/pubmed/32774813 http://dx.doi.org/10.22038/ijbms.2020.38521.9171 |
Ejemplares similares
-
Cloning, Expression, and Refolding of PPE17 Protein of Mycobacterium Tuberculosis as a Promising Vaccine Candidate
por: Najafi, Adel, et al.
Publicado: (2019) -
Detection of anti-HspX antibodies and HspX protein in patient sera for the identification of recent latent infection by Mycobacterium tuberculosis
por: Castro-Garza, Jorge, et al.
Publicado: (2017) -
Evaluating the Performance of PPE44, HSPX, ESAT-6 and CFP-10 Factors in Tuberculosis Subunit Vaccines
por: Valizadeh, Azar, et al.
Publicado: (2022) -
Formulation and Optimization of a New Cationic Lipid-Modified PLGA Nanoparticle as Delivery System for Mycobacterium tuberculosis HspX/EsxS Fusion Protein: An Experimental Design
por: Khademi, Farzad, et al.
Publicado: (2019) -
The ESX-1 Substrate PPE68 Has a Key Function in ESX-1-Mediated Secretion in Mycobacterium marinum
por: Damen, Merel P. M., et al.
Publicado: (2022)